Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 41051-41100 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT06428968
Investigating the Insulin Resistance in Individuals With Type 2 Diabetes
NA
Recruiting
30 participants
Started: Sep 6, 2024 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT06709976
ReceptIVFity & Immunology in ART
N/A
Enrolling by invitation
50 participants
Started: Sep 6, 2024 · Completed: Dec 1, 2025
2 conditions
1 sponsor
1 location
NCT06533969
Assessment of Neural Signals for the Control of Assistive Devices
NA
Recruiting
3 participants
Started: Sep 6, 2024 · Completed: Dec 31, 2027
1 condition
1 sponsor
2 locations
NCT06586658
Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or Relapsed/Metastatic CD70+ Inoperable Renal Cells
EARLY_PHASE1
Recruiting
9 participants
Started: Sep 6, 2024 · Completed: Jul 16, 2027
1 condition
2 sponsors
1 location
NCT06460363
Transcranial Alternating Current Stimulation on Patients with Delirium and Critical Illness (DeliTACS)
NA
Recruiting
78 participants
Started: Sep 6, 2024 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT06378879
Intermittent Boluses Versus Infusion of Propofol During Gastroscopy
NA
Not yet recruiting
100 participants
Started: Sep 6, 2024 · Completed: Jul 30, 2025
1 condition
2 sponsors
0 locations
NCT06786169
The Relationship of Psychological Stress With Therapy Efficacy and Prognosis of Gastric Cancer
N/A
Recruiting
600 participants
Started: Sep 5, 2024 · Completed: Sep 15, 2029
1 condition
1 sponsor
1 location
NCT06962085
Sacral Erector Spinae Plane Block in Transurethral Prostate Resection Surgery
NA
Active, not recruiting
60 participants
Started: Sep 5, 2024 · Completed: Aug 10, 2025
1 condition
1 sponsor
1 location
NCT06571071
A Clinical Study of De-Stress & Chill Gummies in Reducing Stress
NA
Not yet recruiting
72 participants
Started: Sep 5, 2024 · Completed: Dec 28, 2024
2 conditions
1 sponsor
0 locations
NCT06328686
Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain Metastases
EARLY_PHASE1
Recruiting
10 participants
Started: Sep 5, 2024 · Completed: Dec 31, 2027
2 conditions
2 sponsors
1 location
NCT06571318
Clinical Study to Reduce Premature Ejaculation in Healthy Adult Men
NA
Not yet recruiting
60 participants
Started: Sep 5, 2024 · Completed: Dec 28, 2024
2 conditions
1 sponsor
0 locations
NCT06670560
Onco-Respirology Epidemiology Based on Real-world Big Data in Respiratory Medicine
N/A
Active, not recruiting
100,000 participants
Started: Sep 5, 2024 · Completed: Jun 30, 2026
3 conditions
1 sponsor
1 location
NCT06569849
A Clinical Trial of De-stress and Focus Capsule in the Management of Stress.
NA
Not yet recruiting
60 participants
Started: Sep 5, 2024 · Completed: Dec 28, 2024
3 conditions
1 sponsor
0 locations
NCT06790472
Metabolic Wellness and CGM
N/A
Enrolling by invitation
100 participants
Started: Sep 5, 2024 · Completed: Oct 11, 2025
1 condition
3 sponsors
1 location
NCT06571331
A Clinical Trial of De-Stress & Snooze Gummies in Reducing Stress and Insomnia Disorder
NA
Not yet recruiting
60 participants
Started: Sep 5, 2024 · Completed: Dec 28, 2024
3 conditions
1 sponsor
0 locations
NCT06581484
Improving Congenital Heart Disease Care
NA
Recruiting
1,000 participants
Started: Sep 5, 2024 · Completed: Aug 31, 2027
5 conditions
2 sponsors
1 location
NCT06784609
Correlation of Euroscore-II, STS Risk Scoring Systems and Frailty Tests with Cardiac Histopathological Findings in Coronary Bypass Surgery
N/A
Active, not recruiting
50 participants
Started: Sep 5, 2024 · Completed: Apr 1, 2025
9 conditions
1 sponsor
1 location
NCT06248801
Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets
PHASE1
Not yet recruiting
48 participants
Started: Sep 5, 2024 · Completed: Oct 15, 2024
1 condition
1 sponsor
0 locations
NCT06528457
Study to Examine the Effects of Oral Fenretinide
PHASE2
Active, not recruiting
15 participants
Started: Sep 5, 2024 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT06393738
A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
PHASE1
Recruiting
112 participants
Started: Sep 5, 2024 · Completed: Dec 31, 2025
2 conditions
1 sponsor
17 locations
NCT07162844
Foam and Liquid Sclerotherapy With or Without Herbal Gel for Small Vein Treatment
NA
Active, not recruiting
508 participants
Started: Sep 5, 2024 · Completed: Sep 1, 2025
2 conditions
2 sponsors
1 location
NCT05988515
AI-Assisted Treatment for Residual Speech Sound Disorders
NA
Recruiting
26 participants
Started: Sep 5, 2024 · Completed: Dec 31, 2027
1 condition
4 sponsors
1 location
NCT06315192
Stroke Alarm Efficacy Trial
NA
Recruiting
500 participants
Started: Sep 5, 2024 · Completed: Dec 31, 2026
3 conditions
5 sponsors
5 locations
NCT06166654
Optimal Diuretic Therapies for Acute Heart Failure With Volume Overload
PHASE4
Recruiting
939 participants
Started: Sep 5, 2024 · Completed: Sep 30, 2027
1 condition
1 sponsor
3 locations
NCT07163208
Therapeutic Efficacy of Different Wavelengths of Low-Level Laser Therapy in the Treatment of Cervicogenic Headache
NA
Recruiting
150 participants
Started: Sep 5, 2024 · Completed: Oct 5, 2025
1 condition
1 sponsor
1 location
NCT06456320
Mayo Clinic Tapestry 2.0: Applying Multi-Omics for Scientific Discovery
N/A
Enrolling by invitation
10,000 participants
Started: Sep 5, 2024 · Completed: Dec 31, 2027
2 conditions
1 sponsor
3 locations
NCT06606106
A Study of LY3537031 in Overweight, Obese, and Healthy Participants
PHASE1
Active, not recruiting
302 participants
Started: Sep 5, 2024 · Completed: Jul 31, 2026
2 conditions
1 sponsor
5 locations
NCT06068985
Classifying for HER2 Dependence to De-Escalate Neoadjuvant Chemotherapy in Patients With HER2+ Early Breast Cancer Undergoing HER2 Double-Blockade
PHASE2
Recruiting
63 participants
Started: Sep 5, 2024 · Completed: Oct 31, 2031
2 conditions
3 sponsors
7 locations
NCT06685731
Laughter Yoga is Role in Enhancing Sleep and Well-being in the Elderly
NA
Recruiting
60 participants
Started: Sep 5, 2024 · Completed: Dec 31, 2024
1 condition
2 sponsors
1 location
NCT06610578
ICAS Screen Based on RIC
N/A
Recruiting
2,100 participants
Started: Sep 5, 2024 · Completed: Sep 30, 2027
1 condition
1 sponsor
1 location
NCT06571994
The Plastic Exposure Reduction Transforms Health Trial
NA
Recruiting
60 participants
Started: Sep 5, 2024 · Completed: Jun 30, 2025
3 conditions
2 sponsors
1 location
NCT06618716
Individual Differences in Acute Response to Experimental Inflammation: Microcirculatory Changes and Psychological Predictors
NA
Enrolling by invitation
25 participants
Started: Sep 5, 2024 · Completed: Dec 31, 2029
2 conditions
3 sponsors
1 location
NCT06560554
Evaluating the Effects of a Fermented Diet on Microbiome Diversity in Individuals With Long COVID
NA
Enrolling by invitation
40 participants
Started: Sep 5, 2024 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06483035
Treatment of Phantom Limb Pain by Intensive Visual Simulation Therapy
NA
Recruiting
38 participants
Started: Sep 5, 2024 · Completed: Oct 31, 2026
1 condition
1 sponsor
1 location
NCT06453928
Starting Technology in At Risk Type 1 Diabetes Study
NA
Recruiting
40 participants
Started: Sep 5, 2024 · Completed: Jun 30, 2027
1 condition
3 sponsors
2 locations
NCT06373601
SPAGO: Sirolimus Paclitaxel Angiographic Gain Objective
NA
Active, not recruiting
140 participants
Started: Sep 5, 2024 · Completed: Aug 1, 2027
4 conditions
1 sponsor
10 locations
NCT06615713
Evaluate the Safety and Effectiveness of Steerable Ureteroscopic Renal Evacuation (SURE) Using the CVAC® System
NA
Active, not recruiting
40 participants
Started: Sep 5, 2024 · Completed: Nov 30, 2024
3 conditions
1 sponsor
1 location
NCT06562166
Online Adaptive Radiotherapy for Cervical Cancer
PHASE2
Recruiting
124 participants
Started: Sep 5, 2024 · Completed: May 1, 2026
1 condition
6 sponsors
1 location
NCT06580249
Efficacy and Mechanism of rTMS on the Symptoms of Pleasure Deficit in Adolescent Depression
NA
Recruiting
44 participants
Started: Sep 5, 2024 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06636045
Blood Flow Restriction Following ACLR w/Quad Autograft
N/A
Enrolling by invitation
40 participants
Started: Sep 5, 2024 · Completed: Jun 30, 2027
5 conditions
1 sponsor
1 location
NCT06898606
Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression: a Phase 2a Pilot Randomized Clinical Trial (COGUNILA)
PHASE1/PHASE2
Recruiting
24 participants
Started: Sep 5, 2024 · Completed: Nov 20, 2026
1 condition
1 sponsor
1 location
NCT06605755
Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants
NA
Recruiting
785 participants
Started: Sep 5, 2024 · Completed: Feb 28, 2026
5 conditions
1 sponsor
1 location
NCT06466993
Influence of Relaxing Breathing Before Each Station of an Objective Structured Clinical Examination
NA
Not yet recruiting
400 participants
Started: Sep 5, 2024 · Completed: Dec 17, 2024
3 conditions
1 sponsor
0 locations
NCT06569238
Diabetic Foot Ulcer (DFU) Rapid Pathogen Identification
NA
Recruiting
44 participants
Started: Sep 5, 2024 · Completed: Feb 28, 2026
3 conditions
2 sponsors
2 locations
NCT06506890
Study to Determine the Difference in Reduction of Bioaerosols in a Long-term Care Facility
NA
Not yet recruiting
100 participants
Started: Sep 5, 2024 · Completed: Aug 31, 2025
1 condition
2 sponsors
1 location
NCT06260774
Study of TTX-MC138 in Subjects With Advanced Solid Tumors
PHASE1/PHASE2
Active, not recruiting
16 participants
Started: Sep 5, 2024 · Completed: Feb 1, 2027
1 condition
1 sponsor
4 locations
NCT06498583
Effect of Ultrasound-guided Erector Spinae Plane Block on Postoperative Pain and Sleep Quality of Infants With Congenital Pulmonary Cystic Disease After Thoracoscopic Surgery
NA
Recruiting
40 participants
Started: Sep 5, 2024 · Completed: Feb 28, 2025
3 conditions
1 sponsor
1 location
NCT06579768
Radiomics for Preoperative Jaw Cyst Differentiation
N/A
Recruiting
300 participants
Started: Sep 5, 2024 · Completed: Jan 1, 2026
1 condition
12 sponsors
1 location
NCT06353997
Neoadjuvant INBRX-106 (Hexavalent OX40 Agonist) in Combination With Pembrolizumab as a Chemotherapy-sparing Regimen for Stage II TNBC (Triple Negative Breast Cancer) Patients
PHASE2
Recruiting
12 participants
Started: Sep 5, 2024 · Completed: Jun 30, 2029
1 condition
2 sponsors
4 locations
NCT06360380
Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System
NA
Recruiting
40 participants
Started: Sep 5, 2024 · Completed: Jan 29, 2025
2 conditions
1 sponsor
4 locations
Previous
1
More pages
819
820
821
822
823
824
825
More pages
2369
Next